These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30427809)

  • 41. Psychotropics and drug interactions in the elderly patient.
    Katona CL
    Int J Geriatr Psychiatry; 2001 Dec; 16 Suppl 1():S86-90. PubMed ID: 11748792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Managing interactions between cognitive enhancers and other psychotropics.
    Tang SW; Tang WH; Leonard BE
    Int Clin Psychopharmacol; 2017 Jul; 32(4):175-183. PubMed ID: 28234656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First Do No Harm: Psychotropic Prescribing Principles and Guidelines for Older Adults.
    Kverno K
    J Psychosoc Nurs Ment Health Serv; 2020 Aug; 58(8):12-16. PubMed ID: 32744642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacology and Perioperative Considerations for Psychiatric Medications.
    Sadana N; Joshi GP
    Curr Clin Pharmacol; 2017; 12(3):169-175. PubMed ID: 28831913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of drug monotherapy in psychiatric inpatient treatment.
    Rittmannsberger H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):547-51. PubMed ID: 11999906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential drug-drug interactions with psychotropic drugs in paediatric inpatients: A cross-sectional study.
    Yalçın N; Özdemir N; Çak Esen HT; Çengel Kültür SE; Demirkan K
    Int J Clin Pract; 2021 Jun; 75(6):e14107. PubMed ID: 33624394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avoidable drug-gene conflicts and polypharmacy interactions in patients participating in a personalized medicine program.
    Reynolds KK; Pierce DL; Weitendorf F; Linder MW
    Per Med; 2017 May; 14(3):221-233. PubMed ID: 29767587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
    Mark TL
    CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study.
    Pasina L; Marengoni A; Ghibelli S; Suardi F; Djade CD; Nobili A; Franchi C; Guerrini G
    Drugs Aging; 2016 Feb; 33(2):143-9. PubMed ID: 26689398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying and Communicating Clinically Meaningful Drug-Drug Interactions.
    Nelson SD; LaFleur J; Hunter E; Archer M; Steinvoort C; Maden C; Oderda GM
    J Pharm Pract; 2016 Apr; 29(2):110-5. PubMed ID: 25107417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse drug reactions associated with concurrent acute psychiatric treatment and Covid-19 drug therapy.
    Sönmez Güngör E; Yalçın M; Yerebakan Tüzer M; Beşikçi Keleş D; Öcek Baş T; Ergelen M; Bülbül A; Kırşavoğlu B; Güneş M
    Int J Psychiatry Clin Pract; 2021 Jun; 25(2):142-146. PubMed ID: 33143519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Idiosyncratic adverse reactions of most frequent drug combinations longterm use among hospitalized patients with polypharmacy.
    Trumic E; Pranjic N; Begic L; Becic F; Asceric M
    Med Arch; 2012; 66(4):243-8. PubMed ID: 22919879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reasons for polypharmacy among psychiatric patients.
    Viola R; Csukonyi K; Doró P; Janka Z; Soós G
    Pharm World Sci; 2004 Jun; 26(3):143-7. PubMed ID: 15230361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
    Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
    Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
    Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
    J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication use in the elderly patient: focus on the perioperative/perianesthesia setting.
    Kuchta A; Golembiewski J
    J Perianesth Nurs; 2004 Dec; 19(6):415-24; quiz 425-7. PubMed ID: 15801351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychotropic drugs prescription at two regional psychiatric hospitals in northern Nigeria.
    Adeponle AB; Obembe AO; Nnaji F; Adeyemi SO; Suleiman GT
    West Afr J Med; 2008 Apr; 27(2):106-10. PubMed ID: 19025025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug Interactions in Space: a Cause for Concern?
    Berman E; Eyal S
    Pharm Res; 2019 May; 36(8):114. PubMed ID: 31152244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.